| 腫瘍・血液内科学 |
|
|
|
|
|
|
|
| Medical
Oncology and Hematology |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| 整理番号 |
論文の種類 |
著者名 |
論文タイトル |
誌名、書名等 |
巻号ページ |
年 |
doi |
| 2262001 |
原著 |
Onizuka M, Fujii N, Nakasone H, Ogata M, Atsuta Y, Suzuki R,
Uchida N, Ohashi K, Ozawa Y, Eto T, Ikegame K, Nakamae H, Inoue M, Fukuda T |
Risk factors and prognosis of non-infectious pulmonary
complications after allogeneic hematopoietic stem cell transplantation |
Int J Hematol. |
115(4):534-544 |
2022 |
10.1007/s12185-021-03282-9 |
| 2262002 |
原著 |
Marumo A, Wakita S, Morita K, Oh I, Kako S, Toya T, Najima Y,
Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Uoshima N, Kobayashi Y,
Kawata E, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Hagihara M, Uchiyama H,
Kubota Y, Kimura S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M,
Mitsuhashi K, Ando J, Date K, Fujiwara Y, Terada K, Yui S, Arai K, Kitano T,
Miyata M, Ohashi K, Kanda Y, Yamaguchi H. |
NPM1-mutation-based measurable residual disease assessment after
completion of two courses of post-remission therapy is a valuable clinical
predictor of the prognosis of acute myeloid leukemia |
Int J Hematol. |
116(2):199-214. |
2022 |
10.1007/s12185-022-03328-6 |
| 2262003 |
原著 |
Wada Y, Sato T, Hasegawa H, Matsudaira T, Nao N, Coler-Reilly
ALG, Tasaka T, Yamauchi S, Okagawa T, Momose H, Tanio M, Kuramitsu M, Sasaki
D, Matsumoto N, Yagishita N, Yamauchi J, Araya N, Tanabe K, Yamagishi M,
Nakashima M, Nakahata S, Iha H, Ogata M, Muramatsu M, Imaizumi Y, Uchimaru K,
Miyazaki Y, Konnai S, Yanagihara K, Morishita K, Watanabe T, Yamano Y, Saito
M |
RAISING is a high-performance method for identifying random
transgene integration sites |
Commun Biol |
2;5(1):535 |
2022 |
10.1038/s42003-022-03467-w |
| 2262004 |
原著 |
Sumimoto T, Nakahara R, Suzuki Y, Tanaka R, Yoshida N, Ogata M,
Itoh H |
Development of a Sensitive and High-Throughput Assay for
Simultaneous Quantification of 5 Tyrosine Kinase Inhibitors and 2 Active
Metabolites in Human Plasma Using Ultra-high Performance Liquid
Chromatography Coupled to Tandem Mass Spectrometry |
Ther Drug Monit |
44(3):419-429 |
2022 |
10.1097/FTD.0000000000000922 |
| 2262005 |
原著 |
Maeda Y, Tanaka R, Tatsuta R, Takano K, Hashimoto T, Ogata M,
Hiramatsu K, Itoh H |
Impact of inflammation on intra-individual variation in trough
voriconazole concentration in patients with hematological malignancies |
Biol Pharm Bull. |
45(8):1084-1090 |
2022 |
10.1248/bpb.b22-00097 |
| 2262006 |
原著 |
Wakita S, Sakaguchi1 M, Oh I, Kako S, Toya T, Najima Y, Doki N,
Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y,
Kawata E, Tajika K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Kayamori K,
Hagihara H, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T,
Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K,
Ando J, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Arai K, Kitano T,
Miyata M, Kurosawa A, Mizoguchi A, Komatsu N, Fukuda T, Ohashi K, Kanda Y,
Inokuchi K, Yamaguchi H. |
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid
leukemia |
Blood adv. |
11;6(1):238-247 |
2022 |
10.1182/bloodadvances.2021004292 |
| 2262007 |
原著 |
Nosaka K, Kusumoto S, Nakano N, Choi I, Yoshimitsu M, Imaizumi
Y, Hidaka M, Sasaki H, Makiyama J, Ohtsuka E, Jo T, Ogata M, Ito A, Yonekura
K, Tatetsu H, Kato T, Kawakita T, Suehiro Y, Ishitsuka K, Iida S, Matsutani
T, Utsunomiya A, Ueda R, Ishida T |
Clinical significance of the immunoglobulin G heavy-chain
repertoire in peripheral blood mononuclear cells of adult T-cell
leukaemia-lymphoma patients receiving mogamulizumab |
Br J Haematol |
99:87-96 |
2022 |
10.1016/j.clinbiochem.2021.10.010 |
| 2262008 |
原著 |
Tanaka R, Shiraiwa K, Takano K, Ogata M, Honda S, Yoshida N,
Okuhiro K, Yoshida M, Narahara K, Kai M, Tatsuta R, Itoh H |
High-throughput simultaneous quantification of five azole
anti-fungal agents and one active metabolite in human plasma using
ultra-high-performance liquid chromatography coupled to tandem mass
spectrometry. |
Clin Biochem |
99:87-96 |
2022 |
10.1016/j.clinbiochem |
| 2262009 |
原著 |
Fuji S, Hirakawa T, Takano K, Doki N, Sawa M, Kanda Y, Uchida N,
Ara T, Miyamoto T, Eto T, Matsuoka KI, Kawakita T, Ozawa Y, Katayama Y,
Onizuka M, Fukuda T, Atsuta Y, Nakasone H |
Disease-specific impact of anti-thymocyte globulin in allogeneic
hematopoietic cell transplantation: a nationwide retrospective study on
behalf of the JSTCT, transplant complications working group |
Bone Marrow Transplant |
7(3):479-486 |
2022 |
10.1038/s41409-022-01569-x |
| 2262010 |
原著 |
Fuji S, Muta M, Ikeda E, Sakai R, Hagiwara Y, Zaizen K, Makiyama
J, Choi I, Takano K, Koh KR, Ishikawa J. |
Discordance in the morphologic diagnosis of lymphocytes in
HTLV-1-infected individuals |
Int J Lab Hematol. |
44(5):e250-e252 |
2022 |
10.1111/ijlh.13915 |
| 2262011 |
原著 |
Utsunomiya A, Izutsu K, Jo T, Yoshida S, Tsukasaki K, Ando K,
Choi I, Imaizumi Y, Kato K, Kurosawa M, Kusumoto S, Miyagi T, Ohtsuka E,
Sasaki O, Shibayama H, Shimoda K, Takamatsu Y, Takano K, Yonekura K, Makita
S, Taguchi J, Gillings M, Onogi H, Tobinai K |
Oral HDAC Inhibitor Tucidinostat (HBI-8000) in Patients with
Relapsed or Refractory Adult T-cell Leukemia/Lymphoma: Phase IIb Results |
Cancer Sci. |
113(8):2778-2787 |
2022 |
10.1111/cas.15431 |
| 2262012 |
原著 |
Tsukamoto Y,Kurogi S, Shibata T, Suzuki K, Hirashita Y, Fumoto
S, Yano S, Yanagihara K,Nakada C, Mieno F, Kinoshita K, Fuchino T, Mizukami
K, Ueda Y, Etoh T, Uchida T, Hanada T, Takekawa M, Daa T, Shirao K, Hironaka
S, Murakami K, Inomata M,Hijiya N, Moriyama M
|
Enhanced phosphorylation of c-Jun by cisplatin treatment as a
potential predictive biomarker for cisplatin response in combination with
patient-derived tumor organoids.
|
Lab Invest. |
Dec;102(12):1355-1366. |
2022 |
10.1038/s41374-022-00827-2
|
| 2262013 |
原著 |
Komatsu Y, Hironaka
S, Tanizawa Y, Cai Z, Piao Y,
Boku N
|
Treatment Pattern for Advanced Gastric Cancer in Japan and
Factors Associated with Sequential Treatment: A Retrospective Administrative
Claims Database Study
|
Adv Ther. |
39(1):296-313 |
2022 |
10.1007/s12325-021-01931-3 |
| 2262014 |
原著 |
Hironaka S, Sadachi R, Machida N, Iwasa S, Yamada Y, Sasako M,
Yoshikawa T, Boku N, Terashima M
|
Association of renal function with the safety and efficacy of
cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in
patients with advanced gastric cancer: an exploratory analysis of
JCOG1013
|
Jpn J Clin Oncol. |
52(1):14-23 |
2022 |
10.1093/jjco/hyab160 |
| 2262015 |
原著 |
Oshima K, Kato K, Ito Y, Daiko H, Nozaki I, Nakagawa S, Shibuya
Y, Kojima T, Toh Y, Okada M, Hironaka S, Akiyama Y, Komatsu Y, Maejima K,
Nakagawa H, Onuki R, Nagai M, Kato M, Kanato K, Kuchiba A, Nakamura K,
Kitagawa Y
|
Prognostic biomarker study in patients with clinical stage I
esophageal squamous cell carcinoma: JCOG0502-A1
|
Cancer Sci. |
113(3):1018-1027 |
2022 |
10.1111/cas.15251 |
| 2262016 |
原著 |
Mori Y, Kikuchi O, Horimatsu T, Hara H, Hironaka S, Kojima T,
Kato K, Tsushima T, Ishihara R, Mukai K, Uozumi R, Tada H, Kasai H, Kawaguchi
A, Muto M
|
Multicenter phase II study of trifluridine/tipiracil for
esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil,
platinum compounds, and taxanes: the ECTAS study
|
Esophagus. |
19(3):444-451 |
2022 |
10.1007/s10388-021-00905-2 |
| 2262017 |
原著 |
Nishikawa K, Hironaka S, Inagaki T, Komori A, Otsu S, Mitsugi K,
Makiyama A, Watanabe K, Tamura S, Okumura Y, Kusaba H, Esaki T, Baba E,
Shirao K. |
A multicentre retrospective study comparing site-specific
treatment with empiric treatment for unfavourable subset of cancer of unknown
primary site. |
Jpn J Clin Oncol |
Dec 5;52(12):1416-1422 |
2022 |
10.1093/jjco/hyac143 |
| 2262018 |
症例報告 |
Ito T, Takashima A, Yamazaki K, Yukami H, Uetake H, Tsuda M,
Suto T, Moriwaki T, Sugimoto N, Ojima H, Takii Y, Yasui H, Esaki T, Tsuji A,
Goto M, Saruta M, Otsu S, Shinozaki K, Fujiwara T, Tamura T, Baba E, Shiozawa
M, Denda T, Ueno H, Nagashima K, Shimada Y. |
Primary tumor location as a predictor of survival in patients
with RAS wild-type colorectal cancer who receive molecularly targeted drugs
as first-line therapy: a multicente |
Int J Clin Oncol |
Sep;27(9):1450-1458. |
2022 |
10.1007/s10147-022-02208-7 |
| 2262019 |
原著 |
Shibuki T, Mizuta T, Shimokawa M, Koga F, Ueda Y, Nakazawa J,
Komori A, Otsu S, Arima S, Fukahori M, Makiyama A, Taguchi H, Honda T,
Mitsugi K, Nio K, Ide Y, Ureshino N, Shirakawa T, Otsuka T. |
Prognostic nomogram for patients with unresectable pancreatic
cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc
analysis of a multicenter retrospective study in Japan (NAPOLEON study). |
BMC Cancer |
Jan 3;22(1):19 |
2022 |
10.1186/s12885-021-09139-y |
| 2262020 |
原著 |
Koga F, Kawaguchi Y, Shimokawa M, Murayama K, Nakashita S, Oza
N, Ureshino N, Takahashi H, Ueda Y, Nakazawa J, Komori A, Otsu S, Arima S,
Fukahori M, Makiyama A, Taguchi H, Honda T, Shibuki T, Nio K, Ide Y, Mizuta
T, Shirakawa T, Otsuka T, Mitsugi K. |
Gemcitabine plus nab-paclitaxel in older patients with
metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a
multicenter study (the NAPOLEON study) |
J Geriatr Oncol |
Jan;13(1):82-87 |
2022 |
0.1016/j.jgo.2021.06.011. |
| 2262021 |
原著 |
Kimura S, Oshiro Y, Iwasaki H, Kadowaki M, Ogata M, Daa T,
Sakata T, Kawauchi S, Wang Z, Takamatsu Y, Takeshita M |
Clinicopathological findings, prognosis, and Epstein-Barr virus
infection in rheumatoid arthritis patients with other iatrogenic
immunodeficiency-associated T- and NK-cell lymphoproliferative disorders |
BMC Cancer |
Dec 22;22(1):1342 |
2022 |
10.1186/s12885-022-10358-0 |
| 2262022 |
著書 |
緒方正男 |
造血幹細胞移植後のウイルス感染症と対策 |
血液疾患最新の治療 2023-2025 |
267-270 |
2022 |
|
| 2262023 |
総説 |
緒方正男 |
造血幹細胞移植後HHV-6B脳炎の病態と治療 |
血液内科 |
85: 335-341 |
2022 |
|
| 2262024 |
総説 |
緒方正男 |
造血幹細胞移植とHHV-6B |
臨床とウイルス |
50(4), 197-202 |
2022 |
|
|
|
|
|
|
|
|
|